Huang Li
Founding Partner & CEO @ Cowin Capital
Huang Li is a Series A investor at Cowin Capital focused on Biotechnology and Medical Device. Money and Banking Nankai University master's and doctoral finance, global CEO Yangtze classes.Cowin founding partner, Nanhai Growth Fund founding partner. Tianjin Private Equity Association sponsors director.Has 10 years of investment banking qualifications, as the first batch of investment bankers, to witness the growth of China'scapital market, a large number of enterprises to provide financial, restructuring and listing, and financing services.With 20 years of professional experience in securities, investment in the investment banking industry has a profound understanding of the industry has a good relationship with them.
- Total investments:
- 4
- Last investment:
- Lead investor:
- 25%
Last updated:
For AI agents: llms.txt
Industries Huang Li invests in
Stages Huang Li invests in
Countries Huang Li invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Biotechnology 2 (50%)
- Medical Device 2 (50%)
- Pharmaceutical 2 (50%)
- Biopharma 1 (25%)
- Life Science 1 (25%)
Stage
- Series A 2 (50%)
- Seed 1 (25%)
- Series B 1 (25%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| developer of respiratory anti-infection drugs, offering high-potential, low-risk products like new anti-influenza and oral anti-new coronavirus. | $27.6M / Series A / Apr 29, 2024 | ||
| Cosminde is a developer of gastroenterology soft electronic endoscope products. | Series A / Dec 12, 2023 | ||
| Cosminde is a developer of gastroenterology soft electronic endoscope products. | Seed / Jan 16, 2023 | ||
| Wellgrow Technology is a developer of in vitro diagnostic medical equipment and reagents for life sciences, clinical medical diagnostics, and food safety. | Series B / Jan 25, 2022 |
Co-Investors
About Cowin Capital
Cowin Capital is a private placement equity investment company focusing on investing in a pioneering enterprise on a long-term basis. It has 18 years of experience in capital management, whose capital management scale was among the front rank, which invested more than 300 companies, of which 60 more became public companies, and 150 moresuccessfully exit.The company was successfully listed on NEEQ, with code 832793, as the third listed famous domestic venture capital institution in NEEQ. It is committed to supporting the growth of small and medium enterprises, continue to launch high-quality listed companies in China Capital Market.
Cowin Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Cai Weiliang
Partner
|
|||
Ding Baoyu
Managing Director, Partner
|
|||
Dong Dongdong
Partner
|
|||
Dong Ming
Hangzhou Area Partner
|
|||
|
Huang Li
Founding Partner & CEO
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Huang Li invest in?
Huang Li invests primarily in Biotechnology, Medical Device and Pharmaceutical startups, most often at Series A and Seed stage. Most of the 4 investments tracked by Shizune back companies in China. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Huang Li?
For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did Huang Li last invest?
The most recent investment recorded for Huang Li closed in Apr 2024. Shizune tracks 4 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
